029HO11614 JEEVES

Print/PDF
Registration Name KED OUTSIDE JEEVES-ET
Registration Number HOUSA000134438230
Primary NAAB Code 029HO11614
Secondary Code(s) 529HO11614, 531HO11614, 530HO11614, 532HO11614, 533HO11614
Status Inactive
Controller Name ABS Global (29)
Date of Birth 5/22/2003
aAa 513
DMS 345,234
GFI 5.6%
Genetic Codes * TV TL TY
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire COMESTAR OUTSIDE-ET
MGS PEN-COL DUSTER-ET
Beta Casein A1A2
Kappa Casein AA
Beta Lactoglobulin AB
INDEXES
NM$ -209, 97% R CM$ -227
NM Percentile 13% FM$ -170
GTPI 2139 GM$ -170
PRODUCTION TRAITS
51428 Dtrs 10863 herds 21 % US 99% R
Milk -774 Fat, % -42 , -0.04%
SCS 3.2, 99% R Protein, % -33 , -0.03%
Feed Saved -27 , 86% R Milking Speed 7.04 , 83% R
Health & Fertility
Productive Life 2.3      99% R Mastitis 0.9      98% R
Heifer Livability 1.5       95% R Metritis -0.9      97% R
Livability 4.6      99% R D. Abom -1.0      98% R
DPR 4.6      99% R Ketosis -1.6      95% R
HCR 1.1      99% R R. Placenta 0.7      97% R
CCR 4.8      99% R Milk Fever 0.3      92% R
SCR -        -
Calving Traits
Sire CE 2.4      99% R 48734 Obs
Daughter CE 3.8      99% R 19048 Obs, 33011 Dtrs
Sire SB 4.5      99% R 48925 Obs
Daughter SB 4.8      99% R 15678 Obs, Dtrs
Gestation Length 2.8      99% R 1778 Obs, 18394 Dtrs
Early First Calving -2.6      99% R 2168 Obs, 10476 Dtrs

CDCB December 2025; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 12/2025
21490 Dtrs 5960 herds 99% R
PTA Type -1.18 UDC -1.51
FLC 0.08 BWC -0.34
Linear Traits
Stature -1.38
Short
Strength -0.51
Weak
Body Depth -0.76
Shallow
Dairy Form -1.27
Closed
Rump Angle 0.76
Sloped
Thurl Width -1.15
Narrow
Rear Legs-Side View -1.60
Straight
Rear Legs-Rear View 0.11
Straight
Foot Angle 0.01
Steep
Feet & Legs Score -0.26
Low
F.U. Attachment -1.57
Weak
Rear Udder Height -2.60
Low
Rear Udder Width -1.38
Narrow
Udder Cleft -1.75
Weak
Udder Depth -1.10
Deep
Front Teat Placement -0.97
Wide
Rear Teat Placement -1.37
Wide
Teat Length -0.05
Short
-2
0
2

CDCB December 2025; Base of Evaluation: HO